JULIA FREDERICK: Open Payments
NPI 1750166971 · NEWPORT BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,496 in 59 payments from 27 companies in 2025. Trend: 2023 $0 · 2024 $642 · 2025 $1,496
Food & beverage: $1,428Education: $68
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $255 |
| Ardelyx, Inc. | 9 | $194 |
| Apellis Pharmaceuticals, Inc. | 5 | $113 |
| Veloxis Pharmaceuticals, Inc. | 2 | $95 |
| Aimmune Therapeutics, Inc. | 5 | $81 |
| Calliditas Therapeutics US Inc. | 3 | $75 |
| Vifor Pharma, Inc. | 3 | $74 |
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $68 |
| Novo Nordisk Inc | 3 | $65 |
Products named: Repatha, IBSRELA, Empaveli, TARPEYO, Veltassa, JARDIANCE, ZENPEP, BREZTRI.
Industry payments across CA — which companies pay providers there.
